机译:术前化疗术后胰腺腺癌中的淋巴结率与术前化学疗法术后术后化疗
Univ Utah Div Gen Surg Dept Surg 30 North 1900 East Salt Lake City UT 84132 USA;
Univ Utah Dept Radiat Oncol Salt Lake City UT USA;
Univ Utah Dept Radiat Oncol Salt Lake City UT USA;
Univ Utah Div Med Oncol Dept Internal Med Salt Lake City UT USA;
Univ Utah Div Gen Surg Dept Surg 30 North 1900 East Salt Lake City UT 84132 USA;
Univ Utah Dept Radiat Oncol Salt Lake City UT USA;
Univ Utah Dept Radiat Oncol Salt Lake City UT USA;
Univ Utah Div Epidemiol Dept Internal Med Salt Lake City UT USA;
Univ Utah Div Gen Surg Dept Surg 30 North 1900 East Salt Lake City UT 84132 USA;
Univ Utah Div Gen Surg Dept Surg 30 North 1900 East Salt Lake City UT 84132 USA;
LNR; Lymph node ratio; Nodal status; Pancreatic adenocarcinoma; PDAC; Neoadjuvant; Preoperative; Adjuvant; Postoperative; Chemotherapy; Chemoradiation;
机译:术前化疗术后胰腺腺癌中的淋巴结率与术前化学疗法术后术后化疗
机译:术前和术后放化疗,大范围胰腺切除术和术后肝灌注化疗联合治疗胰腺癌局部晚期癌的可行性和有效性
机译:局灶性胃腺癌患者术前用改良FOLFOX6进行化疗,然后进行手术和术后放化疗的II期研究
机译:乳腺癌术前化疗的外科考虑
机译:在乳腺癌新辅助化疗后使用术前Mri引导的活检来预测病理完全缓解
机译:术前与术后化疗和放射治疗淋巴结阳性直肠癌的死亡率风险
机译:化疗与切换为可重症胰腺导管腺癌的术前治疗:倾向评分调整分析